PSNL250117P12500
- 0.00
- 0.000.00%
Personalis Newsroom
The 16% Return This Week Takes Personalis' (NASDAQ:PSNL) Shareholders One-year Gains to 159%
Personalis (PSNL) Gets a Buy From BTIG
Personalis Price Target Raised to $8 From $7 at BTIG
Needham Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $7.25
H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Raises Target Price to $11
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
Strategic Partnerships and Investments Drive Personalis's Growth and Reaffirm Buy Rating
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
Personalis Price Target Maintained With a $7.25/Share by Needham
Personalis Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Personalis, Raises Price Target to $11
Personalis Analyst Ratings
Express News | Personalis Inc : Btig Raises Target Price to $8 From $7
Stock Of The Day: Where Does The Merck Downtrend End?
Personalis Rallies Following $50 Million Investment From Merck, Extended Agreement With Moderna
Merck Buys $50 Million of Personalis Stock
Personalis Signs Multi-Year Extension With Moderna To Utilize Its ImmunoID NeXT Platform And Technology For V940/mRNA-4157
Express News | Personalis Inc: Merck Has Agreed to Purchase $50 Mln of Personalis Common Stock in a Private Placement at a Price of $3.56 per Share
Express News | Personalis Advances Business Strategy With Investment From Merck and Extends Collaboration With Moderna
Tempus AI, Inc (TEM) Expands Partnership With Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma